Concepts (112)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluorescein Angiography | 4 | 2026 | 18 | 1.070 |
Why?
|
| Retinal Vessels | 4 | 2026 | 75 | 1.040 |
Why?
|
| Retinal Vasculitis | 1 | 2026 | 2 | 0.980 |
Why?
|
| Tomography, Optical Coherence | 2 | 2026 | 96 | 0.960 |
Why?
|
| Mutation | 3 | 2024 | 867 | 0.330 |
Why?
|
| Diabetic Retinopathy | 5 | 2022 | 112 | 0.300 |
Why?
|
| Predictive Value of Tests | 3 | 2026 | 485 | 0.240 |
Why?
|
| Sensitivity and Specificity | 3 | 2026 | 524 | 0.230 |
Why?
|
| Retinal Neovascularization | 2 | 2007 | 21 | 0.230 |
Why?
|
| Reproducibility of Results | 4 | 2026 | 787 | 0.230 |
Why?
|
| Retinal Diseases | 1 | 2024 | 47 | 0.210 |
Why?
|
| Middle Aged | 11 | 2026 | 7414 | 0.210 |
Why?
|
| Eye Proteins | 3 | 2020 | 207 | 0.200 |
Why?
|
| Macular Edema | 1 | 2022 | 3 | 0.190 |
Why?
|
| Prospective Studies | 1 | 2026 | 1280 | 0.190 |
Why?
|
| Indians, North American | 6 | 2011 | 544 | 0.180 |
Why?
|
| Punctal Plugs | 1 | 2021 | 3 | 0.170 |
Why?
|
| Dry Eye Syndromes | 1 | 2021 | 5 | 0.170 |
Why?
|
| Aged | 5 | 2026 | 5598 | 0.170 |
Why?
|
| Retinitis Pigmentosa | 1 | 2020 | 33 | 0.160 |
Why?
|
| Choroidal Neovascularization | 1 | 2000 | 11 | 0.160 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 1 | 2020 | 57 | 0.160 |
Why?
|
| Diabetes Mellitus | 1 | 2022 | 215 | 0.160 |
Why?
|
| Anemia, Sickle Cell | 1 | 2000 | 39 | 0.160 |
Why?
|
| Adult | 5 | 2026 | 8024 | 0.150 |
Why?
|
| Female | 11 | 2026 | 15624 | 0.150 |
Why?
|
| Phenotype | 1 | 2020 | 685 | 0.140 |
Why?
|
| Male | 10 | 2026 | 13921 | 0.140 |
Why?
|
| Retina | 4 | 2022 | 445 | 0.130 |
Why?
|
| Humans | 14 | 2026 | 28851 | 0.130 |
Why?
|
| Fundus Oculi | 4 | 2002 | 15 | 0.120 |
Why?
|
| Retinal Degeneration | 2 | 2002 | 156 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 2005 | 58 | 0.100 |
Why?
|
| Visual Acuity | 3 | 2020 | 119 | 0.090 |
Why?
|
| Child, Preschool | 3 | 2024 | 1173 | 0.090 |
Why?
|
| Child | 4 | 2024 | 2287 | 0.080 |
Why?
|
| Macular Degeneration | 1 | 2011 | 85 | 0.080 |
Why?
|
| Photography | 4 | 2022 | 19 | 0.080 |
Why?
|
| Adolescent | 4 | 2024 | 3193 | 0.070 |
Why?
|
| Pedigree | 3 | 2020 | 155 | 0.070 |
Why?
|
| Macula Lutea | 1 | 1987 | 5 | 0.070 |
Why?
|
| Genes, Dominant | 1 | 1987 | 35 | 0.070 |
Why?
|
| Receptors, LDL | 1 | 2007 | 28 | 0.070 |
Why?
|
| Neovascularization, Pathologic | 1 | 1987 | 148 | 0.060 |
Why?
|
| Visually Impaired Persons | 1 | 2005 | 5 | 0.060 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2005 | 254 | 0.060 |
Why?
|
| Eye Diseases | 1 | 2005 | 31 | 0.060 |
Why?
|
| Vision Disorders | 1 | 2005 | 38 | 0.060 |
Why?
|
| Young Adult | 2 | 2024 | 2833 | 0.060 |
Why?
|
| Oklahoma | 6 | 2011 | 1052 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2024 | 68 | 0.050 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2002 | 3 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2007 | 1507 | 0.040 |
Why?
|
| Tears | 1 | 2021 | 10 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 2021 | 8 | 0.040 |
Why?
|
| Intravitreal Injections | 1 | 2021 | 34 | 0.040 |
Why?
|
| Eye | 1 | 2021 | 36 | 0.040 |
Why?
|
| Ophthalmology | 1 | 2001 | 37 | 0.040 |
Why?
|
| Laser Coagulation | 1 | 2000 | 13 | 0.040 |
Why?
|
| Hypertension | 2 | 2011 | 309 | 0.040 |
Why?
|
| Aged, 80 and over | 3 | 2011 | 2065 | 0.030 |
Why?
|
| Prevalence | 2 | 2011 | 518 | 0.030 |
Why?
|
| Visual Field Tests | 2 | 2002 | 16 | 0.030 |
Why?
|
| Ophthalmoscopy | 1 | 1993 | 6 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 1993 | 344 | 0.020 |
Why?
|
| Sunlight | 1 | 2011 | 11 | 0.020 |
Why?
|
| Vitamins | 1 | 2011 | 23 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2011 | 58 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2011 | 64 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 410 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 467 | 0.020 |
Why?
|
| Risk Factors | 2 | 2011 | 2126 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2011 | 176 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 737 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2011 | 897 | 0.020 |
Why?
|
| Vision, Ocular | 1 | 1987 | 27 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2007 | 21 | 0.020 |
Why?
|
| Electrophysiology | 1 | 1987 | 150 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2007 | 50 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2007 | 18 | 0.020 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 24 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2007 | 59 | 0.020 |
Why?
|
| Serpins | 1 | 2007 | 31 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2007 | 88 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 328 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2007 | 191 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 179 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 157 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2007 | 465 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2007 | 585 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2007 | 515 | 0.010 |
Why?
|
| Exudates and Transudates | 1 | 2005 | 11 | 0.010 |
Why?
|
| Retinal Hemorrhage | 1 | 2005 | 7 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 2005 | 31 | 0.010 |
Why?
|
| Aneurysm | 1 | 2005 | 25 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 874 | 0.010 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2002 | 6 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2005 | 995 | 0.010 |
Why?
|
| Dark Adaptation | 1 | 2002 | 13 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 270 | 0.010 |
Why?
|
| Electroretinography | 1 | 2002 | 180 | 0.010 |
Why?
|
| Mice | 1 | 2007 | 4802 | 0.010 |
Why?
|
| Animals | 1 | 2007 | 10684 | 0.010 |
Why?
|
| Diabetic Nephropathies | 1 | 1992 | 21 | 0.010 |
Why?
|
| Diabetic Angiopathies | 1 | 1992 | 48 | 0.010 |
Why?
|
| Triglycerides | 1 | 1992 | 123 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1992 | 357 | 0.010 |
Why?
|
| Cholesterol | 1 | 1992 | 203 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1992 | 310 | 0.010 |
Why?
|
| Incidence | 1 | 1992 | 572 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 1992 | 1032 | 0.000 |
Why?
|
| Time Factors | 1 | 1992 | 1613 | 0.000 |
Why?
|